Skip to main content

Table 1 Baseline characteristics in both groups

From: Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

  Range Mean ± S.D t test p-value
Age Group I 33–63 47.48 ± 7.36 0.030 0.863
Group II 33–65 47.75 ± 6.82
Sex   Group I Group II Total
Male N 22 30 52
% 55.0% 75.0% 65.0%
Female N 18 10 28
% 45.0% 25.0% 35.0%
Total N 40 40 80
% 100.0% 100.0% 100.0%
Chi-square X2 3.516
p-value 0.0610.061